WELLS FARGO & COMPANY/MN - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 64 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$921,262
-55.6%
1,039,799
-21.3%
0.00%
-100.0%
Q3 2022$2,074,000
-6.8%
1,320,592
+19.3%
0.00%0.0%
Q2 2022$2,225,000
-28.7%
1,106,556
-17.4%
0.00%0.0%
Q1 2022$3,120,000
-42.5%
1,339,186
+14.8%
0.00%0.0%
Q4 2021$5,424,000
-23.2%
1,166,363
+26.0%
0.00%
-50.0%
Q3 2021$7,060,000
-11.8%
925,445
+12.0%
0.00%0.0%
Q2 2021$8,009,000
+21.6%
826,533
+3.7%
0.00%
+100.0%
Q1 2021$6,589,000
-5.4%
796,850
-21.9%
0.00%
-50.0%
Q4 2020$6,965,000
-18.7%
1,020,563
+25.0%
0.00%0.0%
Q3 2020$8,565,000
+126.3%
816,604
+35.5%
0.00%
+100.0%
Q2 2020$3,784,000
+2810.8%
602,493
+755.0%
0.00%
Q1 2020$130,000
-73.2%
70,468
-50.9%
0.00%
Q4 2019$485,000
+90.9%
143,648
+20.8%
0.00%
Q3 2019$254,000
-17.5%
118,882
+2.9%
0.00%
Q2 2019$308,000
-68.8%
115,540
-44.5%
0.00%
Q1 2019$988,000
+127.1%
208,203
+14.9%
0.00%
Q4 2018$435,000
-35.7%
181,234
+17.7%
0.00%
Q3 2018$677,000
-84.6%
153,917
-74.8%
0.00%
-100.0%
Q2 2018$4,406,000
+70.7%
611,968
+22.1%
0.00%0.0%
Q1 2018$2,581,000
+25710.0%
501,200
+19948.0%
0.00%
Q4 2017$10,000
+150.0%
2,5000.0%0.00%
Q3 2017$4,000
-98.9%
2,500
-97.3%
0.00%
Q1 2017$362,000
-41.0%
91,593
-26.9%
0.00%
Q4 2016$614,000
+372.3%
125,261
+644.0%
0.00%
Q3 2016$130,000
+30.0%
16,837
-5.6%
0.00%
Q2 2016$100,000
-16.7%
17,837
-20.6%
0.00%
Q1 2016$120,000
-31.0%
22,454
+12.5%
0.00%
Q4 2015$174,000
+5.5%
19,959
+1.5%
0.00%
Q3 2015$165,000
-24.7%
19,669
+58.4%
0.00%
Q2 2015$219,000
-37.8%
12,421
-59.2%
0.00%
Q1 2015$352,00030,428
+3042700.0%
0.00%
Q4 2014$010.0%0.00%
Q3 2014$010.0%0.00%
Q2 2014$0
-100.0%
1
-100.0%
0.00%
Q1 2014$81,0006,298
+629700.0%
0.00%
Q4 2013$010.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders